Wilson Sonsini is pleased to be a 2025 sponsor of the Pharmaceutical and Biomedical Sciences Society International (PBSS).

This workshop will describe and discuss approaches, with case studies, that address the iterative, interdependent, multidisciplinary nature of effective drug product development, with focus on small molecules that require enabling technologies.

Discussion Topics Include:

• Use of Quality Target Product Profiles (QTPPs) to guide product development strategy (single presentation)
• The state of the art in enabling technologies (SDDs, HME/kinetisol, Lipid-based, nanoparticles, other)
• Translational aspects of formulation development and drug product development
• Use of AI/ML and lab automation to optimize and test attributes and feasibility of pharmaceutical blends
• 3D printing for drug product manufacture

Firm partner Julia Minitti will lead the session, IP Considerations for Development and Implementation of Enabling Technologies.

For more information or passes to this event please contact Marketing.